Wufan Tao

4.0k citations
39 papers · 3.2k indexed · h-index 24
Topics
Hippo pathway signaling and YAP/TAZ (18 papers)Wnt/β-catenin signaling in development and cancer (5 papers)Microtubule and mitosis dynamics (4 papers)
Partner nations
ChinaUnited StatesRussia

In The Last Decade

Wufan Tao

36 papers receiving 3.1k citations

Peers

Wufan Tao
Comparison fields: 5 of 110
  • Molecular Biology 2.1k
  • Cell Biology 1.4k
  • Oncology 367
  • Immunology 350
  • Cancer Research 350
Replace Keyong Du with:
Keyong Du United States
Alexandre Blais Canada
Sandy M. Price United States
Dorothea Rudolph Austria
Athanassia Sotiropoulos France
Mervyn J. Monteiro United States
Norihisa Masuyama Japan
Núria de la Iglesia Spain
Emilia Turco Italy
James M. Angelastro United States
Wufan Tao relative to Keyong Du United States Keyong Du's profile →
Citations per field
00.5×1.5×2.2×
Keyong Du · 1×
Citations per year

Countries citing papers authored by Wufan Tao

Since Specialization
Citations

This map shows the geographic impact of Wufan Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wufan Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wufan Tao more than expected).

Fields of papers citing papers by Wufan Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wufan Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wufan Tao. The network helps show where Wufan Tao may publish in the future.

Co-authorship network of co-authors of Wufan Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Wufan Tao. A scholar is included among the top collaborators of Wufan Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wufan Tao. Wufan Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 7
5 18
6 8
7 48
8 87
9 59
10 127
11 67
12 49
13 3
14 9
15 81
16 89
17 159
18 134
19 471
20 11

About Wufan Tao

Wufan Tao is a scholar working on Cell Biology, Molecular Biology and Oncology, having authored 39 papers that have together received 3.2k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (18 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Cell Biology (1.4k citations), Aging (61 citations) and Developmental Neuroscience (133 citations). Wufan Tao has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Tian Xu, Eseng Lai, Carlos Baptista, Shouhong Xuan, Maie A.R. St. John, Jing Pei, Xia Hong, Yunfang Li, Albert F. Parlow and James McGrath. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026